Health
Analysis Questions Trump’s Pharma Deals
A new analysis suggests that Trump's 'most-favored nation' pricing policy could be undermined by secretive deals with pharmaceutical companies, potentially reducing projected savings.
Coverage timeline — 1 article
STAT News
The projected savings from Trump's "most-favored nation" pricing policy might be drastically reduced by secretive deals with pharma companies, a new analysis finds.
2026-09-13 22:30 UTC